rs104886247

Variant summary

Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM2PM5PP3_StrongPP5

The NM_033380.3(COL4A5):​c.3632G>A​(p.Gly1211Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,097,559 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1211R) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 9.1e-7 ( 0 hom. 0 hem. )

Consequence

COL4A5
NM_033380.3 missense

Scores

14
2
1

Clinical Significance

Pathogenic no assertion criteria provided P:1

Conservation

PhyloP100: 9.46
Variant links:
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 9 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrnull-null-null-null is described in UniProt as null.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.996
PP5
Variant X-108668346-G-A is Pathogenic according to our data. Variant chrX-108668346-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 24662.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chrX-108668346-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL4A5NM_033380.3 linkuse as main transcriptc.3632G>A p.Gly1211Glu missense_variant 41/53 ENST00000328300.11 NP_203699.1 P29400-2Q49AM6A7MBN3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL4A5ENST00000328300.11 linkuse as main transcriptc.3632G>A p.Gly1211Glu missense_variant 41/531 NM_033380.3 ENSP00000331902.7 P29400-2
COL4A5ENST00000361603.7 linkuse as main transcriptc.3632G>A p.Gly1211Glu missense_variant 41/512 ENSP00000354505.2 P29400-1

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
AF:
9.11e-7
AC:
1
AN:
1097559
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
363087
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000119
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Alport syndrome Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingSydney Genome Diagnostics, Children's Hospital WestmeadNov 09, 2014This patient is heterozygous for the c.3632G>A p.(Gly1211Glu) variant in the COL4A5 gene. This variant has been previously reported as part of a complex allele, in a patient with Alport syndrome (Knebelmann et al., 1996, Am. J. Hum. Genet. 59:1221-1232 - PMID 1914854). In silico analysis (Alamut Visual v2.6) using PolyPhen2, SIFT and Mutation Taster all predict this variant to be likely pathogenic, however, Align GVGD predicts this variant to be benign. This variant lies in the collagen triple helix repeat domain and mutations involving glycine residues have been implicated in Alport's syndrome. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Pathogenic
0.74
D
BayesDel_noAF
Pathogenic
0.82
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.93
.;D
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D;D
M_CAP
Pathogenic
0.98
D
MetaRNN
Pathogenic
1.0
D;D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
4.6
H;H
PrimateAI
Pathogenic
0.86
D
PROVEAN
Pathogenic
-7.4
D;D
REVEL
Pathogenic
0.99
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
.;D
Vest4
1.0
MutPred
1.0
Gain of catalytic residue at G1211 (P = 0.2277);Gain of catalytic residue at G1211 (P = 0.2277);
MVP
1.0
MPC
0.39
ClinPred
1.0
D
GERP RS
6.0
Varity_R
0.99
gMVP
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs104886247; hg19: chrX-107911576; API